Tolvaptan
156-KOB-1101i
Approved small_molecule terminated
Quick answer
Tolvaptan for Hyponatremia and Extracellular Fluid in Cirrhotic is a Approved program (small_molecule) at Otsuka Beijing Research Institute with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Otsuka Beijing Research Institute
- Indication
- Hyponatremia and Extracellular Fluid in Cirrhotic
- Phase
- Approved
- Modality
- small_molecule
- Status
- terminated